WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012112566) PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/112566    International Application No.:    PCT/US2012/025068
Publication Date: 23.08.2012 International Filing Date: 14.02.2012
Chapter 2 Demand Filed:    17.12.2012    
IPC:
A61K 31/4174 (2006.01), A61K 9/00 (2006.01), A61P 17/00 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive Irvine, California 92886 (US) (For All Designated States Except US).
SHANLER, Stuart, D. [US/US]; (US) (For US Only).
POWALA, Christopher [US/US]; (US) (For US Only)
Inventors: SHANLER, Stuart, D.; (US).
POWALA, Christopher; (US)
Agent: BANERJEE, Krishna; Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 (US).
HOFFMANN, Eitle; Patent- und Rechtsanwälte Arabellastrasse 4 D-81925 munich (DE)
Priority Data:
61/443,210 15.02.2011 US
Title (EN) PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA
(FR) COMPOSITIONS DE CRÈME PHARMACEUTIQUE À BASE D'OXYMÉTAZOLINE POUR LE TRAITEMENT DES SYMPTÔMES DE L'ACNÉ ROSACÉE
Abstract: front page image
(EN)The present invention is directed to: a) a method of treating telangiectasia; b) a method of treating inflammatory lesions; and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.
(FR)La présente invention concerne : a) un procédé de traitement de la télangiectasie; b) un procédé de traitement de lésions inflammatoires; et c) un procédé de traitement d'au moins deux symptômes de l'acné rosacée choisis parmi l'érythème, la télangiectasie, ou les lésions inflammatoires comprenant l'administration topique d'une composition pharmaceutique comprenant de l'oxymétazoline et un excipient pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)